Opportunity ID: 329170

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-20-509
Funding Opportunity Title: Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 22, 2020
Last Updated Date: Sep 22, 2020
Original Closing Date for Applications: Feb 09, 2021
Current Closing Date for Applications: Feb 09, 2021
Archive Date: Mar 17, 2021
Estimated Total Program Funding:
Award Ceiling: $2,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites one application from the Program Director(s)/Principal Investigator(s) of the current Integrated Islet Distribution Program (IIDP) to renew the program andmaintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research.The IIDP facilitates the distribution of human islets to biomedical researchers byestablishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. The programmanages an application process to establish investigator eligibility to receive islet shipments, informs investigators of islet availability, manages a cost recovery system through fees collected from islet recipients, and oversees standardized phenotypic and genotypic analyses of islet preparations distributed throughout theIIDP network. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapiesfor the prevention and treatment of diabetes.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-509.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00263526 Jan 09, 2021 Feb 09, 2021 View

Package 1

Mandatory forms

329170 RR_SF424_2_0-2.0.pdf

329170 PHS398_CoverPageSupplement_5_0-5.0.pdf

329170 RR_OtherProjectInfo_1_4-1.4.pdf

329170 PerformanceSite_2_0-2.0.pdf

329170 RR_KeyPersonExpanded_2_0-2.0.pdf

329170 RR_Budget_1_4-1.4.pdf

329170 PHS398_ResearchPlan_4_0-4.0.pdf

329170 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

329170 RR_SubawardBudget30_1_4-1.4.pdf

329170 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T15:39:39-05:00

Share This Post, Choose Your Platform!

About the Author: